Showing 1211-1220 of 1363 results for "".
Acquired Dermal Macular Hyperpigmentation
https://practicaldermatology.com/topics/pigmentary-disorders/acquired-dermal-macular-hyperpigmentation/67257/Acquired dermal macular hyperpigmentation (ADMH) encompasses a group of chronic acquired pigmentary dermatoses characterized by the presence of dermal pigmentation.Selecting the Optimal JAK Inhibitor for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/selecting-the-optimal-jak-inhibitor-for-alopecia-areata/67265/Since 2022, the US Food and Drug Administration (FDA) has approved three oral JAK inhibitors: baricitinib, ritlecitinib, and deuruxolitinib.Top Developments in Vitiligo
https://practicaldermatology.com/topics/pigmentary-disorders/top-developments-in-vitiligo/67259/Vitiligo is no longer an afterthought in dermatology research.Best Practices for Photodynamic Therapy for Actinic Keratosis
https://practicaldermatology.com/columns/skin-cancer-essentials/best-practices-for-photodynamic-therapy-for-actinic-keratosis/67261/Photodynamic therapy (PDT) remains an effective field-directed treatment for actinic keratoses (AKs)Mohs Micrographic Surgery Access and Distribution Lacking in Louisiana
https://practicaldermatology.com/topics/skin-cancer-photoprotection/mohs-micrographic-surgery-access-and-distribution-lacking-in-louisiana/67058/New Frontiers in Skin Cancer Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/new-frontiers-in-skin-cancer-management/57249/Across the spectrum of diagnosis, prognostication, prevention, and treatment, advances in technology and therapeutics are reshaping how clinicians care for patients with skin cancer. This issue highlights innovations and insights that are changing the field and offers a glimpse of where skin cancerThe Hidradenitis Suppurativa Therapeutic Pipeline
https://practicaldermatology.com/topics/rare-disease/the-hidradenitis-suppurativa-therapeutic-pipeline/54824/Though treatment options are currently limited, the pipeline for HS therapeutics is active with numerous medications in development.10 Procedural Tips for Hidradenitis Suppurativa
https://practicaldermatology.com/topics/rare-disease/10-procedural-tips-for-hidradenitis-suppurativa/56430/This guide was created to assist dermatologists who care for patients with HS considering surgery and emphasizes the importance of patient-centered care, expectation setting, and advanced surgical techniques.A New Era in Hidradenitis Suppurativa Care
https://practicaldermatology.com/topics/rare-disease/a-new-era-in-hidradenitis-suppurativa-care/56428/Remarkable innovation is happening in HS. Ultimately, it comes down to this: we are now able to provide patients with a level of care that was not previously possible because so many new therapies are being unlocked.Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occu